Old Web
English
Sign In
Acemap
>
authorDetail
>
Julia Hurrelbrink
Julia Hurrelbrink
Duke University
Sipuleucel-T
Medicine
Radium-223
Oncology
Pathology
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized phase II trial of sipuleucel-T with or without radium-223 in men with bone-metastatic castration-resistant prostate cancer
2021
Clinical Cancer Research
Catherine Handy Marshall
Wei Fu
Hao Wang
Jong Chul Park
Theodore L. DeWeese
Phuoc T. Tran
Danny Y. Song
Serina King
Michaella Afful
Julia Hurrelbrink
Charlotte E Manogue
Patrick Cotogno
Nancy P. Moldawer
Pedro C. Barata
Charles G. Drake
Edwin M. Posadas
Andrew J. Armstrong
Oliver Sartor
Emmanuel S. Antonarakis
Show All
Source
Cite
Save
Citations (7)
Results of the randomized phase II study of sipuleucel-T (Sip-T) +/- Radium-223 (Ra-223) in men with bone-metastatic castration resistant prostate cancer.
2020
Journal of Clinical Oncology
Catherine Handy Marshall
Jong Chul Park
Wei Fu
Hao Wang
Theodore L. DeWeese
Serina King
Michaella Afful
Julia Hurrelbrink
Charlotte Manogue
Patrick Cotogno
Nancy P. Moldawer
Pedro C. Barata
Charles G. Drake
Edwin M. Posadas
Andrew J. Armstrong
A. Oliver Sartor
Emmanuel S. Antonarakis
Show All
Source
Cite
Save
Citations (0)
Randomized phase II study of sipuleucel-T (SipT) with or without radium-223 (Ra223) in men with asymptomatic bone-metastatic castrate-resistant prostate cancer (mCRPC).
2020
Journal of Clinical Oncology
Catherine Handy Marshall
Jong Chul Park
Theodore L. DeWeese
Serina King
Michaella Afful
Julia Hurrelbrink
Charlotte Manogue
Patrick Cotogno
Nancy P. Moldawer
Pedro C. Barata
Charles G. Drake
Edwin M. Posadas
Andrew J. Armstrong
A. Oliver Sartor
Emmanuel S. Antonarakis
Show All
Source
Cite
Save
Citations (4)
1